Fort Washington Investment Advisors Inc. OH raised its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 17.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,089,654 shares of the pharmacy operator’s stock after acquiring an additional 163,148 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in CVS Health were worth $48,915,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new stake in CVS Health during the third quarter worth $31,000. Reston Wealth Management LLC purchased a new position in CVS Health in the third quarter valued at $32,000. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the third quarter worth about $33,000. 80.66% of the stock is owned by hedge funds and other institutional investors.
CVS Health Trading Up 1.0 %
NYSE CVS opened at $53.14 on Wednesday. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The stock has a market capitalization of $66.87 billion, a P/E ratio of 13.49, a PEG ratio of 0.79 and a beta of 0.59. The firm’s 50-day moving average is $51.27 and its two-hundred day moving average is $56.29. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 5.01%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on CVS. Evercore ISI upped their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research report on Tuesday, October 1st. Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Finally, Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $68.71.
Get Our Latest Analysis on CVS Health
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- Comparing and Trading High PE Ratio Stocks
- SAP’s Strong Momentum: A Bullish Setup for Investors
- How to Plot Fibonacci Price Inflection Levels
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.